Awake fiberoptic intubation vs video laryngoscopy in predicted difficult airway: when to choose which?
48M scheduled for thyroid surgery with a large retrosternal goiter causing tracheal deviation and compression. CT shows the trachea narrowed to 6mm at the point of maximum compression. Mallampati IV. Neck extension limited.
My dilemma: Traditional teaching says awake fiberoptic intubation (AFOI) is the gold standard for predicted difficult airways. But video laryngoscopy (VL) with devices like the C-MAC D-blade has improved dramatically.
Questions:
- In 2026, is AFOI still the default for anticipated difficult airways?
- What is your threshold for tracheal compression below which you MUST use AFOI?
- How do you prepare a patient for AFOI (topicalization protocol)?
- Contingency plan if AFOI fails in this setting?
1 Answer
AFOI remains my default for this specific scenario (retrosternal goiter with tracheal compression < 8mm). Here is why:
1. AFOI vs VL: Video laryngoscopy has improved first-pass intubation rates dramatically for difficult airways caused by poor mouth opening, anterior larynx, or cervical immobility. But VL does NOT help you navigate a compressed, deviated trachea. The advantage of AFOI is that you visualize the tracheal lumen directly and pass the bronchoscope through the narrowed segment under direct vision before advancing the ETT. With VL, you see the vocal cords but are "blind" to the sub-glottic pathology.
2. Tracheal compression threshold: If CT shows tracheal lumen < 8mm at any point, I default to AFOI. Between 8 to 10mm, I consider VL with the patient spontaneously breathing. Above 10mm with no other difficult airway predictors, standard VL is reasonable.
3. Topicalization protocol:
- Glycopyrrolate 0.2mg IV 30 minutes before (antisialagogue)
- 4% lidocaine nebulization for 10 minutes (oropharynx and larynx)
- 2% lidocaine gargle for 1 minute (oropharynx)
- Transtracheal injection of 2mL 4% lidocaine through cricothyroid membrane (subglottic anesthesia), this is the most critical step for suppressing cough during bronchoscope advancement
- Remifentanil infusion at 0.05 to 0.1 mcg/kg/min for patient comfort without respiratory depression
- Target: patient alert, cooperative, spontaneously breathing, minimal cough
4. Contingency plan: If AFOI fails (e.g., patient cannot tolerate the procedure despite adequate topicalization, or anatomy prevents scope advancement):
- First backup: nasal AFOI if oral route failed
- Second backup: VL-assisted intubation with patient still awake and spontaneously breathing
- Emergency surgical airway (tracheostomy under local anesthesia) must be available and the ENT surgeon scrubbed. In retrosternal goiter, cricothyrotomy may not be feasible due to the mass; a formal tracheostomy is the safer rescue.